FDA Fleshes Out Stance On Fast-Track Device Approvals
The U.S. Food and Drug Administration on Wednesday outlined intricate policies that will govern a new streamlined approval pathway for medical devices that improve on existing therapies, expanding significantly on draft...To view the full article, register now.
Already a subscriber? Click here to view full article